| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Cardiovascular Biology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104; and
Howard Hughes Medical Institute, Oklahoma City, OK 73104
The protein C pathway is a primary regulator of blood coagulation and a critical component of the host response to inflammatory stimuli. The most recent member of this pathway is the endothelial protein C receptor (EPCR), a type I transmembrane protein with homology to CD1d/MHC class I proteins. EPCR accelerates formation of activated protein C, a potent anticoagulant and antiinflammatory agent. The current study demonstrates that soluble EPCR binds to PMA-activated neutrophils. Using affinity chromatography, binding studies with purified components, and/or blockade with specific Abs, it was found that soluble EPCR binds to proteinase-3 (PR3), a neutrophil granule proteinase. Furthermore, soluble EPCR binding to neutrophils was partially dependent on Mac-1 (CD11b/CD18), a ß2 integrin involved in neutrophil signaling, and cell-cell adhesion events. PR3 is involved in multiple diverse processes, including hemopoietic proliferation, antibacterial activity, and autoimmune-mediated vasculitis. The observation that soluble EPCR binds to activated neutrophils via PR3 and a ß2 integrin suggests that there may be a link between the protein C anticoagulant pathway and neutrophil functions.
This article has been cited by other articles:
|
|
 |
|
  S. Gandrille Endothelial cell protein C receptor and the risk of venous thrombosis Haematologica, June 1, 2008; 93(6): 812 - 816. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Saposnik, E. Lesteven, A. Lokajczyk, C. T. Esmon, M. Aiach, and S. Gandrille Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma Blood, April 1, 2008; 111(7): 3442 - 3451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin The cytoprotective protein C pathway Blood, April 15, 2007; 109(8): 3161 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thiyagarajan, T. Cheng, and B. V. Zlokovic Endothelial Cell Protein C Receptor: Role Beyond Endothelium? Circ. Res., February 2, 2007; 100(2): 155 - 157. [Full Text] [PDF]
|
|
|
|
|
|
X. Zheng, W. Li, J.-M. Gu, D. Qu, G. L. Ferrell, N. L. Esmon, and C. T. Esmon Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice Blood, February 1, 2007; 109(3): 1003 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ludeman, H. Kataoka, Y. Srinivasan, N. L. Esmon, C. T. Esmon, and S. R. Coughlin PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin J. Biol. Chem., April 1, 2005; 280(13): 13122 - 13128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iwaki, D. T. Cruz, J. A. Martin, and F. J. Castellino A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse Blood, March 15, 2005; 105(6): 2364 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. de Wouwer, D. Collen, and E. M. Conway Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1374 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Opal The nexus between systemic inflammation and disordered coagulation in sepsis Innate Immunity, April 1, 2004; 10(2): 125 - 129. [Abstract] [PDF]
|
|
|
|
 |
|
 A. David, Y. Kacher, U. Specks, and I. Aviram Interaction of proteinase 3 with CD11b/CD18 ({beta}2integrin) on the cell membrane of human neutrophils J. Leukoc. Biol., October 1, 2003; 74(4): 551 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Esmon The Protein C Pathway Chest, September 1, 2003; 124(3_suppl): 26S - 32S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Sturn, N. C. Kaneider, C. Feistritzer, A. Djanani, K. Fukudome, and C. J. Wiedermann Expression and function of the endothelial protein C receptor in human neutrophils Blood, August 15, 2003; 102(4): 1499 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Esmon Coagulation and inflammation Innate Immunity, June 1, 2003; 9(3): 192 - 198. [Abstract] [PDF]
|
|
|
|
 |
|
 G. A. Preston, C. S. Zarella, W. F. Pendergraft III, E. H. Rudolph, J. J. Yang, S. B. Sekura, J. C. Jennette, and R. J. Falk Novel Effects of Neutrophil-Derived Proteinase 3 and Elastase on the Vascular Endothelium Involve In Vivo Cleavage of NF-{kappa}B and Proapoptotic Changes in JNK, ERK, and p38 MAPK Signaling Pathways J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2840 - 2849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gu, J. T. B. Crawley, G. Ferrell, F. Zhang, W. Li, N. L. Esmon, and C. T. Esmon Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic Lethality J. Biol. Chem., November 1, 2002; 277(45): 43335 - 43343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Esmon New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins J. Exp. Med., September 2, 2002; 196(5): 561 - 564. [Full Text] [PDF]
|
|
|
|
|
|
V. Oganesyan, N. Oganesyan, S. Terzyan, D. Qu, Z. Dauter, N. L. Esmon, and C. T. Esmon The Crystal Structure of the Endothelial Protein C Receptor and a Bound Phospholipid J. Biol. Chem., July 5, 2002; 277(28): 24851 - 24854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Kim, P. L. Walinsky, F. D. Kolodgie, C. Bian, J. L. Sperry, C. B. Deming, E. A. Peck, J. G. Shake, G. B. Ang, R. H. Sohn, et al. Early Loss of Thrombomodulin Expression Impairs Vein Graft Thromboresistance: Implications for Vein Graft Failure Circ. Res., February 8, 2002; 90(2): 205 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Stearns-Kurosawa, K. Swindle, A. D'Angelo, P. Della Valle, A. Fattorini, N. Caron, M. Grimaux, B. Woodhams, and S. Kurosawa Plasma levels of endothelial protein C receptor respond to anticoagulant treatment Blood, January 15, 2002; 99(2): 526 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. G. Laszik, X. J. Zhou, G. L. Ferrell, F. G. Silva, and C. T. Esmon Down-Regulation of Endothelial Expression of Endothelial Cell Protein C Receptor and Thrombomodulin in Coronary Atherosclerosis Am. J. Pathol., September 1, 2001; 159(3): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Faust, M. Levin, O. B. Harrison, R. D. Goldin, M. S. Lockhart, S. Kondaveeti, Z. Laszik, C. T. Esmon, and R. S. Heyderman Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis N. Engl. J. Med., August 9, 2001; 345(6): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Kim, P. L. Walinsky, F. D. Kolodgie, C. Bian, J. L. Sperry, C. B. Deming, E. A. Peck, J. G. Shake, G. B. Ang, R. H. Sohn, et al. Early Loss of Thrombomodulin Expression Impairs Vein Graft Thromboresistance: Implications for Vein Graft Failure Circ. Res., February 8, 2002; 90(2): 205 - 212. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
